Clinical Trial Update: Positron Emission Tomography (PET) Study of Changes in [11C]AZ14132516 Uptake Following Administration of AZD7798 to Healthy Participants and Patients With Crohn's Disease [Phase 1]

View source ↗

Summary

Phase 1 PET imaging study evaluating changes in [11C]AZ14132516 uptake after administration of AZD7798 in healthy participants and Crohn's disease patients; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• AZD7798 (AZD7798)
• [11C]AZ14132516 (AZ14132516)

Snippet

Sponsor: AstraZeneca | Conditions: Crohn's Disease | Phase 1 | Status: COMPLETED